Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jan 24;12(2):118. doi: 10.3390/vaccines12020118

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Serum-neutralizing GMTs (95% CIs) before and 1 month after vaccination with XBB.1.5-adapted BNT162b2 30 μg and GMFRs (95% CIs) from before to 1 month after vaccination to Omicron XBB.1.5 (a), EG.5.1 (b), and BA.2.86 (c). Data are for the evaluable immunogenicity population. Assay results <LLOQ were set to 0.5 × LLOQ. Numbers within the bars are the GMTs. 1m = 1 month after vaccination; FFRNT = fluorescent focus reduction neutralization test; GMFR = geometric mean fold rise; GMT = geometric mean titer; LLOQ = lower limit of quantitation; Pre = before vaccination.